Cargando…

Low Serum Potassium Levels and Clinical Outcomes in Peritoneal Dialysis—International Results from PDOPPS

INTRODUCTION: Hypokalemia, including normal range values <4 mEq/l, has been associated with increased peritonitis and mortality in patients with peritoneal dialysis. This study sought to describe international variation in hypokalemia, potential modifiable hypokalemia risk factors, and the covari...

Descripción completa

Detalles Bibliográficos
Autores principales: Davies, Simon J., Zhao, Junhui, Morgenstern, Hal, Zee, Jarcy, Bieber, Brian, Fuller, Douglas S., Sloand, James A., Vychytil, Andreas, Kawanishi, Hideki, Johnson, David W., Wang, Angela Yee-Moon, Kanjananbuch, Talerngsak, Boongird, Sarinya, Moraes, Thyago P., Badve, Sunil V., Pisoni, Ronald L., Perl, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879114/
https://www.ncbi.nlm.nih.gov/pubmed/33615056
http://dx.doi.org/10.1016/j.ekir.2020.11.021
_version_ 1783650465753333760
author Davies, Simon J.
Zhao, Junhui
Morgenstern, Hal
Zee, Jarcy
Bieber, Brian
Fuller, Douglas S.
Sloand, James A.
Vychytil, Andreas
Kawanishi, Hideki
Johnson, David W.
Wang, Angela Yee-Moon
Kanjananbuch, Talerngsak
Boongird, Sarinya
Moraes, Thyago P.
Badve, Sunil V.
Pisoni, Ronald L.
Perl, Jeffrey
author_facet Davies, Simon J.
Zhao, Junhui
Morgenstern, Hal
Zee, Jarcy
Bieber, Brian
Fuller, Douglas S.
Sloand, James A.
Vychytil, Andreas
Kawanishi, Hideki
Johnson, David W.
Wang, Angela Yee-Moon
Kanjananbuch, Talerngsak
Boongird, Sarinya
Moraes, Thyago P.
Badve, Sunil V.
Pisoni, Ronald L.
Perl, Jeffrey
author_sort Davies, Simon J.
collection PubMed
description INTRODUCTION: Hypokalemia, including normal range values <4 mEq/l, has been associated with increased peritonitis and mortality in patients with peritoneal dialysis. This study sought to describe international variation in hypokalemia, potential modifiable hypokalemia risk factors, and the covariate-adjusted relationship of hypokalemia with peritonitis and mortality. METHODS: Baseline serum potassium was determined in 7421 patients from 7 countries in the Peritoneal Dialysis Outcomes and Practice Patterns Study (2014–2017). Association of baseline patient and treatment factors with subsequent serum potassium <4 mEq/l was evaluated by logistic regression, whereas baseline serum potassium levels (4-month average and fraction of 4 months having hypokalemia) on clinical outcomes was assessed by Cox regression. RESULTS: Hypokalemia was more prevalent in Thailand and among black patients in the United States. Characteristics/treatments associated with potassium <4 mEq/l included protein-energy wasting indicators, lower urine volume, lower blood pressure, higher dialysis dose, greater diuretic use, and not being prescribed a renin-angiotensin system inhibitor. Persistent hypokalemia (all 4 months vs. 0 months over the 4-month exposure period) was associated with 80% higher subsequent peritonitis rates (at K <3.5 mEq/l) and 40% higher mortality (at K <4.0 mEq/l) after extensive case mix/potential confounding adjustments. Furthermore, adjusted peritonitis rates were higher if having mean serum K over 4 months <3.5 mEq/l versus 4.0–4.4 mEq/l (hazard ratio, 1.15 [95% confidence interval, 0.96–1.37]), largely because of Gram-positive/culture-negative infections. CONCLUSIONS: Persistent hypokalemia is associated with higher mortality and peritonitis even after extensive adjustment for patient factors. Further studies are needed to elucidate mechanisms of these poorer outcomes and modifiable risk factors for persistent hypokalemia.
format Online
Article
Text
id pubmed-7879114
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-78791142021-02-18 Low Serum Potassium Levels and Clinical Outcomes in Peritoneal Dialysis—International Results from PDOPPS Davies, Simon J. Zhao, Junhui Morgenstern, Hal Zee, Jarcy Bieber, Brian Fuller, Douglas S. Sloand, James A. Vychytil, Andreas Kawanishi, Hideki Johnson, David W. Wang, Angela Yee-Moon Kanjananbuch, Talerngsak Boongird, Sarinya Moraes, Thyago P. Badve, Sunil V. Pisoni, Ronald L. Perl, Jeffrey Kidney Int Rep Clinical Research INTRODUCTION: Hypokalemia, including normal range values <4 mEq/l, has been associated with increased peritonitis and mortality in patients with peritoneal dialysis. This study sought to describe international variation in hypokalemia, potential modifiable hypokalemia risk factors, and the covariate-adjusted relationship of hypokalemia with peritonitis and mortality. METHODS: Baseline serum potassium was determined in 7421 patients from 7 countries in the Peritoneal Dialysis Outcomes and Practice Patterns Study (2014–2017). Association of baseline patient and treatment factors with subsequent serum potassium <4 mEq/l was evaluated by logistic regression, whereas baseline serum potassium levels (4-month average and fraction of 4 months having hypokalemia) on clinical outcomes was assessed by Cox regression. RESULTS: Hypokalemia was more prevalent in Thailand and among black patients in the United States. Characteristics/treatments associated with potassium <4 mEq/l included protein-energy wasting indicators, lower urine volume, lower blood pressure, higher dialysis dose, greater diuretic use, and not being prescribed a renin-angiotensin system inhibitor. Persistent hypokalemia (all 4 months vs. 0 months over the 4-month exposure period) was associated with 80% higher subsequent peritonitis rates (at K <3.5 mEq/l) and 40% higher mortality (at K <4.0 mEq/l) after extensive case mix/potential confounding adjustments. Furthermore, adjusted peritonitis rates were higher if having mean serum K over 4 months <3.5 mEq/l versus 4.0–4.4 mEq/l (hazard ratio, 1.15 [95% confidence interval, 0.96–1.37]), largely because of Gram-positive/culture-negative infections. CONCLUSIONS: Persistent hypokalemia is associated with higher mortality and peritonitis even after extensive adjustment for patient factors. Further studies are needed to elucidate mechanisms of these poorer outcomes and modifiable risk factors for persistent hypokalemia. Elsevier 2020-11-22 /pmc/articles/PMC7879114/ /pubmed/33615056 http://dx.doi.org/10.1016/j.ekir.2020.11.021 Text en © 2020 International Society of Nephrology. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Clinical Research
Davies, Simon J.
Zhao, Junhui
Morgenstern, Hal
Zee, Jarcy
Bieber, Brian
Fuller, Douglas S.
Sloand, James A.
Vychytil, Andreas
Kawanishi, Hideki
Johnson, David W.
Wang, Angela Yee-Moon
Kanjananbuch, Talerngsak
Boongird, Sarinya
Moraes, Thyago P.
Badve, Sunil V.
Pisoni, Ronald L.
Perl, Jeffrey
Low Serum Potassium Levels and Clinical Outcomes in Peritoneal Dialysis—International Results from PDOPPS
title Low Serum Potassium Levels and Clinical Outcomes in Peritoneal Dialysis—International Results from PDOPPS
title_full Low Serum Potassium Levels and Clinical Outcomes in Peritoneal Dialysis—International Results from PDOPPS
title_fullStr Low Serum Potassium Levels and Clinical Outcomes in Peritoneal Dialysis—International Results from PDOPPS
title_full_unstemmed Low Serum Potassium Levels and Clinical Outcomes in Peritoneal Dialysis—International Results from PDOPPS
title_short Low Serum Potassium Levels and Clinical Outcomes in Peritoneal Dialysis—International Results from PDOPPS
title_sort low serum potassium levels and clinical outcomes in peritoneal dialysis—international results from pdopps
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879114/
https://www.ncbi.nlm.nih.gov/pubmed/33615056
http://dx.doi.org/10.1016/j.ekir.2020.11.021
work_keys_str_mv AT daviessimonj lowserumpotassiumlevelsandclinicaloutcomesinperitonealdialysisinternationalresultsfrompdopps
AT zhaojunhui lowserumpotassiumlevelsandclinicaloutcomesinperitonealdialysisinternationalresultsfrompdopps
AT morgensternhal lowserumpotassiumlevelsandclinicaloutcomesinperitonealdialysisinternationalresultsfrompdopps
AT zeejarcy lowserumpotassiumlevelsandclinicaloutcomesinperitonealdialysisinternationalresultsfrompdopps
AT bieberbrian lowserumpotassiumlevelsandclinicaloutcomesinperitonealdialysisinternationalresultsfrompdopps
AT fullerdouglass lowserumpotassiumlevelsandclinicaloutcomesinperitonealdialysisinternationalresultsfrompdopps
AT sloandjamesa lowserumpotassiumlevelsandclinicaloutcomesinperitonealdialysisinternationalresultsfrompdopps
AT vychytilandreas lowserumpotassiumlevelsandclinicaloutcomesinperitonealdialysisinternationalresultsfrompdopps
AT kawanishihideki lowserumpotassiumlevelsandclinicaloutcomesinperitonealdialysisinternationalresultsfrompdopps
AT johnsondavidw lowserumpotassiumlevelsandclinicaloutcomesinperitonealdialysisinternationalresultsfrompdopps
AT wangangelayeemoon lowserumpotassiumlevelsandclinicaloutcomesinperitonealdialysisinternationalresultsfrompdopps
AT kanjananbuchtalerngsak lowserumpotassiumlevelsandclinicaloutcomesinperitonealdialysisinternationalresultsfrompdopps
AT boongirdsarinya lowserumpotassiumlevelsandclinicaloutcomesinperitonealdialysisinternationalresultsfrompdopps
AT moraesthyagop lowserumpotassiumlevelsandclinicaloutcomesinperitonealdialysisinternationalresultsfrompdopps
AT badvesunilv lowserumpotassiumlevelsandclinicaloutcomesinperitonealdialysisinternationalresultsfrompdopps
AT pisonironaldl lowserumpotassiumlevelsandclinicaloutcomesinperitonealdialysisinternationalresultsfrompdopps
AT perljeffrey lowserumpotassiumlevelsandclinicaloutcomesinperitonealdialysisinternationalresultsfrompdopps
AT lowserumpotassiumlevelsandclinicaloutcomesinperitonealdialysisinternationalresultsfrompdopps